{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:43:58Z","timestamp":1790516638587,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Papillomavirus Research"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.pvr.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T01:46:37Z","timestamp":1503020797000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Modulation of antigen presenting cell functions during chronic HPV infection"],"prefix":"10.1016","volume":"4","author":[{"given":"Abate Assefa","family":"Bashaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Leggatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janin","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewen K.","family":"Tuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Frazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pvr.2017.08.002_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.pvr.2017.08.002_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jana.2015.07.001","article-title":"Human papillomavirus biology, pathogenesis, and potential for drug discovery: a literature review for HIV nurse clinical scientists","volume":"26","author":"Walhart","year":"2015","journal-title":"J. Assoc. Nurses AIDS Care"},{"key":"10.1016\/j.pvr.2017.08.002_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"The Cancer Genome Atlas","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pvr.2017.08.002_bib4","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/ncomms3513","article-title":"The landscape of viral expression and host gene fusion and adaptation in human cancer","volume":"4","author":"Tang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pvr.2017.08.002_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejca.2016.08.012","article-title":"CD8+ T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer","volume":"67","author":"Masterson","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.pvr.2017.08.002_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3892\/ol.2015.3295","article-title":"Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer","volume":"10","author":"Song","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.pvr.2017.08.002_bib7","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.18632\/oncotarget.1934","article-title":"An updated overview of HPV-associated head and neck carcinomas","volume":"5","author":"Zaravinos","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.pvr.2017.08.002_bib8","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3390\/v7072802","article-title":"Human papillomaviruses; epithelial tropisms, and the development of neoplasia","volume":"7","author":"Egawa","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.pvr.2017.08.002_bib9","unstructured":"National Institute of Health. Papillomavirus Episteme. \u3008https:\/\/pave.niaid.nih.gov\/#search\/search_database\u3009 (Accessed 6 August 2017), 2017."},{"key":"10.1016\/j.pvr.2017.08.002_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5468\/ogs.2015.58.1.40","article-title":"Type-specific persistence or regression of human papillomavirus genotypes in women with cervical intraepithelial neoplasia 1: a prospective cohort study","volume":"58","author":"Cho","year":"2015","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.pvr.2017.08.002_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues","volume":"7","author":"Woodman","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pvr.2017.08.002_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53","volume":"529","author":"Martinez-Zapien","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pvr.2017.08.002_bib13","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1128\/JVI.79.17.11392-11402.2005","article-title":"Examination of the pRb-dependent and pRb-independent functions of E7 in vivo","volume":"79","author":"Balsitis","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.pvr.2017.08.002_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/S1516-31802003000300009","article-title":"Regulation of cell cycles is of key importance in human papillomavirus (HPV)-associated cervical carcinogenesis","volume":"121","author":"Brenna","year":"2003","journal-title":"Sao Paulo Med. J."},{"key":"10.1016\/j.pvr.2017.08.002_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10156-012-0485-5","article-title":"Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer","volume":"18","author":"Sasagawa","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.pvr.2017.08.002_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000357187","article-title":"Management of cutaneous human papillomavirus infection in immunocompromised patients","volume":"45","author":"Varada","year":"2014","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.pvr.2017.08.002_bib17","first-page":"19","article-title":"Higher prevalence of human papillomavirus-related cervical precancerous abnormalities in HIV-infected compared to HIV-uninfected women","volume":"108","author":"Choudhury","year":"2016","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.pvr.2017.08.002_bib18","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/ijc.28309","article-title":"Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma","volume":"133","author":"De Vos van Steenwijk","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pvr.2017.08.002_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/exd.13334","article-title":"Epidermal keratinocytes sense dsRNA via the NLRP3 inflammasome, mediating interleukin (IL)-1beta and IL-18 release","author":"Dai","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.pvr.2017.08.002_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2249.2006.03258.x","article-title":"Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin","volume":"147","author":"Sugita","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib21","doi-asserted-by":"crossref","first-page":"e17848","DOI":"10.1371\/journal.pone.0017848","article-title":"Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes","volume":"6","author":"Karim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2017.08.002_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.jid.5700530","article-title":"Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9","volume":"127","author":"Lebre","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.pvr.2017.08.002_bib23","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1128\/JVI.02151-15","article-title":"Downregulation of toll-like receptor 9 expression by beta human papillomavirus 38 and implications for cell cycle control","volume":"89","author":"Pacini","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.pvr.2017.08.002_bib24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.20122394","article-title":"The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter","volume":"210","author":"Hasan","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pvr.2017.08.002_bib25","doi-asserted-by":"crossref","first-page":"12922","DOI":"10.1038\/srep12922","article-title":"The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes","volume":"5","author":"Richards","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pvr.2017.08.002_bib26","first-page":"9","article-title":"Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response","author":"Karim","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pvr.2017.08.002_bib27","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1038\/ncomms7537","article-title":"The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NF\u03baB activation","volume":"6","author":"Tummers","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pvr.2017.08.002_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003536","article-title":"Post-translational control of IL-1\u03b2 via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53","volume":"9","author":"Niebler","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pvr.2017.08.002_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2016.00496","article-title":"Human papillomavirus downregulates the expression of IFITM1 and RIPK3 to escape from IFNgamma- and TNFalpha-mediated antiproliferative effects and necroptosis","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.07.044","article-title":"HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells","volume":"407","author":"Campo","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.pvr.2017.08.002_bib31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/ijc.25004","article-title":"All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization","volume":"126","author":"Cortese","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pvr.2017.08.002_bib32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1742-4658.2011.08011.x","article-title":"Human papillomavirus 16 E7 protein inhibits interferon-gamma-mediated enhancement of keratinocyte antigen processing and T-cell lysis","volume":"278","author":"Zhou","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.pvr.2017.08.002_bib33","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1099\/vir.0.054486-0","article-title":"Human papillomavirus 16-encoded E7 protein inhibits IFN-gamma-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes","volume":"94","author":"Zhou","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.pvr.2017.08.002_bib34","doi-asserted-by":"crossref","first-page":"9486","DOI":"10.1128\/JVI.05007-11","article-title":"Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance","volume":"85","author":"Hong","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.pvr.2017.08.002_bib35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ni.1724","article-title":"Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells","volume":"10","author":"Bedoui","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.immuni.2013.10.004","article-title":"Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin","volume":"39","author":"Tamoutounour","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.pvr.2017.08.002_bib37","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20101102","article-title":"Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons","volume":"207","author":"Gregorio","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pvr.2017.08.002_bib38","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ni.2680","article-title":"The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells","volume":"14","author":"Heath","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2014.10.023","article-title":"The immunology of the porcine skin and its value as a model for human skin","volume":"66","author":"Summerfield","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20101824","article-title":"Cutaneous immunosurveillance by self-renewing dermal gammadelta T cells","volume":"208","author":"Sumaria","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pvr.2017.08.002_bib41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nri2455","article-title":"Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells","volume":"8","author":"Merad","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1189\/jlb.1HI0714-351R","article-title":"Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells","volume":"97","author":"Bigley","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.pvr.2017.08.002_bib43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ni852","article-title":"Langerhans cells renew in the skin throughout life under steady-state conditions","volume":"3","author":"Merad","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib44","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1056\/NEJM200412163512523","article-title":"Turnover of epidermal Langerhans' cells","volume":"351","author":"Kanitakis","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pvr.2017.08.002_bib45","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pvr.2017.08.002_bib46","doi-asserted-by":"crossref","first-page":"e1019198","DOI":"10.1080\/2162402X.2015.1019198","article-title":"Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103- and XCR1+CD103+ dendritic cells","volume":"4","author":"Wylie","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pvr.2017.08.002_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.2795","article-title":"Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation","volume":"15","author":"Vander Lugt","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib48","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4049\/jimmunol.1403134","article-title":"Tumor-infiltrating dendritic cells in cancer pathogenesis","volume":"194","author":"Tran Janco","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib49","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/jid.2009.266","article-title":"Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections","volume":"130","author":"Leong","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.pvr.2017.08.002_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.virol.2013.06.020","article-title":"High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells","volume":"444","author":"Lijima","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.pvr.2017.08.002_bib51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2005.02282.x","article-title":"High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract","volume":"117","author":"Jimenez-Flores","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.pvr.2017.08.002_bib52","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.4238\/2015.September.8.8","article-title":"Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells","volume":"14","author":"Jiang","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.pvr.2017.08.002_bib53","doi-asserted-by":"crossref","first-page":"34789","DOI":"10.1038\/srep34789","article-title":"Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice","volume":"6","author":"Jemon","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pvr.2017.08.002_bib54","doi-asserted-by":"crossref","first-page":"e1002833","DOI":"10.1371\/journal.ppat.1002833","article-title":"Human papillomavirus type 8 interferes with a novel C\/EBPbeta-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration","volume":"8","author":"Sperling","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pvr.2017.08.002_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10517-014-2491-3","article-title":"Distribution of antigen-presenting cells CD68 in papillomavirus infection in the skin","volume":"157","author":"Reva","year":"2014","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.pvr.2017.08.002_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2016.129","article-title":"Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota","author":"Shannon","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2016.08.016","article-title":"Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas","volume":"62","author":"Kindt","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pvr.2017.08.002_bib58","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1128\/JVI.79.23.14852-14862.2005","article-title":"Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6\/E7 is related to reduced macrophage inflammatory protein-3alpha production","volume":"79","author":"Guess","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.pvr.2017.08.002_bib59","doi-asserted-by":"crossref","first-page":"e48954","DOI":"10.1371\/journal.pone.0048954","article-title":"Transcriptional repression of E-cadherin by human papillomavirus type 16 E6","volume":"7","author":"D'Costa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2017.08.002_bib60","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.1771","article-title":"E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions","volume":"206","author":"Hubert","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.pvr.2017.08.002_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","article-title":"Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell crosspriming in vivo","volume":"24","author":"Le Borgne","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.pvr.2017.08.002_bib62","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.192.5.705","article-title":"Macrophage inflammatory protein 3\u03b1 Is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting langerhans cell precursors","volume":"192","author":"Dieu-Nosjean","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pvr.2017.08.002_bib63","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/eji.201545917","article-title":"Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation","volume":"46","author":"Wang","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib64","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ni.3396","article-title":"Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-beta","volume":"17","author":"Mohammed","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/eji.201242654","article-title":"E-cadherin interactions are required for Langerhans cell differentiation","volume":"43","author":"Mayumi","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00262-008-0522-5","article-title":"Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20","volume":"58","author":"Caberg","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.pvr.2017.08.002_bib67","first-page":"8","article-title":"Human papillomavirus type 8 interferes with a novel C\/EBP\u03b2-mediated mechanism of keratinocyte CCL20 chemokine expression and langerhans cell migration","author":"Sperling","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pvr.2017.08.002_bib68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1590\/S0102-8650201400160007","article-title":"Progressive loss of E-cadherin immunoexpression during cervical carcinogenesis","volume":"29","author":"Cavalcante","year":"2014","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.pvr.2017.08.002_bib69","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00404-015-3787-x","article-title":"HPV-16 E6\/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo","volume":"292","author":"Hu","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.pvr.2017.08.002_bib70","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s10637-012-9803-0","article-title":"Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression","volume":"30","author":"D'Costa","year":"2012","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.pvr.2017.08.002_bib71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ni.2195","article-title":"NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8+ T cells","volume":"13","author":"Kupz","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib72","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4014\/jmb.1611.11072","article-title":"Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B5, a Mucosal Adjuvant Derived from a Type II Heat-Labile Enterotoxin of Escherichia coli","volume":"27","author":"Lee","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.pvr.2017.08.002_bib73","doi-asserted-by":"crossref","first-page":"39894","DOI":"10.18632\/oncotarget.9529","article-title":"Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression","volume":"7","author":"Verma","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pvr.2017.08.002_bib74","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.0105-2896.2009.00887.x","article-title":"DC subsets in positive and negative regulation of immunity","volume":"234","author":"Coquerelle","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pvr.2017.08.002_bib75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/imm.12101","article-title":"Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia","volume":"139","author":"Yang","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.pvr.2017.08.002_bib76","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clim.2015.09.003","article-title":"Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C","volume":"161","author":"Da Silva","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pvr.2016.01.002","article-title":"T cell ignorance is bliss: t cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation","volume":"2","author":"Woodham","year":"2016","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.pvr.2017.08.002_bib79","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.virol.2014.01.031","article-title":"Suppression of Langerhans cell activation is conserved amongst human papillomavirus \u03b1 and \u03b2 genotypes, but not a \u03bc genotype","volume":"0","author":"Da Silva","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.pvr.2017.08.002_bib80","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.4049\/jimmunol.0902145","article-title":"A major role for the minor capsid protein of human papillomavirus type 16 in immune escape","volume":"183","author":"Fahey","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib81","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/eji.201444594","article-title":"Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer","volume":"44","author":"Langers","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib82","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1303190","article-title":"Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression","volume":"192","author":"Woodham","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/jir.2015.0115","article-title":"Immunostimulatory activity of the cytokine-based biologic, IRX-2, on human papillomavirus-exposed langerhans cells","volume":"36","author":"Da Silva","year":"2016","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.pvr.2017.08.002_bib84","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/viro.1998.9128","article-title":"Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes","volume":"244","author":"Doan","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.pvr.2017.08.002_bib85","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/jvi.70.3.1873-1881.1996","article-title":"Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene","volume":"70","author":"Herber","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.pvr.2017.08.002_bib86","doi-asserted-by":"crossref","first-page":"e57798","DOI":"10.1371\/journal.pone.0057798","article-title":"Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes","volume":"8","author":"Choyce","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2017.08.002_bib87","doi-asserted-by":"crossref","first-page":"e0127155","DOI":"10.1371\/journal.pone.0127155","article-title":"Langerhans cell homeostasis and activation is altered in hyperplastic human papillomavirus type 16 E7 expressing epidermis","volume":"10","author":"Abd Warif","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2017.08.002_bib88","doi-asserted-by":"crossref","first-page":"e0152886","DOI":"10.1371\/journal.pone.0152886","article-title":"Epithelium expressing the E7 oncoprotein of HPV16 attracts immune-modulatory dendritic cells to the skin and suppresses their antigen-processing capacity","volume":"11","author":"Chandra","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pvr.2017.08.002_bib89","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2013.222","article-title":"Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7","volume":"133","author":"Mittal","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.pvr.2017.08.002_bib90","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ni.2992","article-title":"Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin","volume":"15","author":"Natsuaki","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/iid3.21","article-title":"HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models","volume":"2","author":"Stone","year":"2014","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.pvr.2017.08.002_bib92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imm.12487","article-title":"Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions","volume":"146","author":"Prata","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.pvr.2017.08.002_bib93","doi-asserted-by":"crossref","first-page":"6891482","DOI":"10.1155\/2016\/6891482","article-title":"Elevated expression of programmed death-1 and programmed death ligand-1 negatively regulates immune response against cervical cancer cells","volume":"2016","author":"Chen","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.pvr.2017.08.002_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2016.03.007","article-title":"Inflammatory microenvironment and human papillomavirus-induced carcinogenesis","author":"Mangino","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.pvr.2017.08.002_bib95","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/mi.2008.33","article-title":"Evolving immunosuppressive microenvironment during human cervical carcinogenesis","volume":"1","author":"Kobayashi","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib96","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5306\/wjco.v5.i4.753","article-title":"Role of IL-10 and TGF-beta1 in local immunosuppression in HPV-associated cervical neoplasia","volume":"5","author":"Torres-Poveda","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.pvr.2017.08.002_bib97","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00262-008-0584-4","article-title":"High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells","volume":"58","author":"Herfs","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.pvr.2017.08.002_bib98","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.archoralbio.2015.10.013","article-title":"Overexpression of immunosuppressive cytokines is associated with poorer clinical stage of oral squamous cell carcinoma","volume":"61","author":"Arantes","year":"2016","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.pvr.2017.08.002_bib99","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.4049\/jimmunol.1301693","article-title":"Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10\/MARCH1-dependent mechanism","volume":"191","author":"Chattopadhyay","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4049\/jimmunol.0802047","article-title":"IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host","volume":"183","author":"Liu","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib101","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cyto.2015.09.001","article-title":"Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-beta1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity","volume":"76","author":"Garcia-Rocha","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.pvr.2017.08.002_bib102","doi-asserted-by":"crossref","first-page":"e1008334","DOI":"10.1080\/2162402X.2015.1008334","article-title":"Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion","volume":"4","author":"Demoulin","year":"2015","journal-title":"Oncoimmunology"},{"issue":"241\u2013254","key":"10.1016\/j.pvr.2017.08.002_bib103","first-page":"254","article-title":"In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity","volume":"256","author":"Vicari","year":"2004","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.pvr.2017.08.002_bib104","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3519745","article-title":"Adenovirus-mediated CCR7 and BTLA overexpression enhances immune tolerance and migration in immature dendritic cells","volume":"2017","author":"Xin","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pvr.2017.08.002_bib105","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/ijc.28549","article-title":"Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells","volume":"134","author":"Pahne-Zeppenfeld","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pvr.2017.08.002_bib106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pvr.2017.08.002_bib107","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1038\/cti.2016.16","article-title":"OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer","volume":"5","author":"Montler","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib108","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12253-011-9471-y","article-title":"Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression","volume":"18","author":"Kosmaczewska","year":"2012","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.pvr.2017.08.002_bib109","unstructured":"National Cancer Institute, A Phase I Trial of Sequential Ipilimumab After Chemoradiation for the Primary Treatment of Patients With Locally Advanced Cervical Cancer Stages IB2\/IIA With Positive Para-Aortic Lymph Nodes Only and Stage IIB\/IIIB\/IVA With Positive Lymph Nodes. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01711515\u3009 (Accessed 7 August 2017). ClinicalTrials.gov Identifier: NCT01711515."},{"key":"10.1016\/j.pvr.2017.08.002_bib110","article-title":"Current studies of immunotherapy in head and neck cancer","author":"Dogan","year":"2017","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.pvr.2017.08.002_bib111","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/jid.2012.16","article-title":"gammadelta T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen","volume":"132","author":"Rahimpour","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.pvr.2017.08.002_bib112","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/jid.2010.17","article-title":"Antigen-specific CD4 cells assist CD8 T-effector cells in eliminating keratinocytes","volume":"130","author":"Broom","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.pvr.2017.08.002_bib113","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/jnci\/djh301","article-title":"Impaired antigen presentation and effectiveness of combined active\/passive immunotherapy for epithelial tumors","volume":"96","author":"Matsumoto","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.pvr.2017.08.002_bib114","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.4049\/jimmunol.167.11.6180","article-title":"Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure","volume":"167","author":"Frazer","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib115","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.vaccine.2015.02.019","article-title":"Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation","volume":"33","author":"Lee","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.pvr.2017.08.002_bib116","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/eji.200838527","article-title":"Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cells","volume":"39","author":"Narayan","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib117","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.1100756","article-title":"NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins","volume":"187","author":"Mattarollo","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib118","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.4049\/jimmunol.1000400","article-title":"On\/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1d-mediated interaction with invariant NKT cells","volume":"185","author":"Caielli","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13000-015-0254-8","article-title":"Accumulation of invariant NKT cells with increased IFN-gamma production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia","volume":"10","author":"Hu","year":"2015","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.pvr.2017.08.002_bib120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib121","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1440-1797.2007.00921.x","article-title":"Indoleamine 2,3-dioxygenase in transplantation","volume":"13","author":"Mulley","year":"2008","journal-title":"Nephrol. (Carlton)"},{"key":"10.1016\/j.pvr.2017.08.002_bib122","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.clinbiochem.2016.04.008","article-title":"Analysis of Kynurenine\/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients","volume":"49","author":"Hascitha","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.pvr.2017.08.002_bib123","doi-asserted-by":"crossref","first-page":"e981457","DOI":"10.4161\/2162402X.2014.981457","article-title":"Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival","volume":"4","author":"Ferns","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pvr.2017.08.002_bib124","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2010.02.028","article-title":"Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy","volume":"117","author":"Inaba","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.pvr.2017.08.002_bib125","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.4049\/jimmunol.179.10.7176","article-title":"IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions","volume":"179","author":"Seresini","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.pvr.2017.08.002_bib126","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells","volume":"33","author":"Stevanovic","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pvr.2017.08.002_bib127","first-page":"53","article-title":"Predominant overexpression of CD25\/FOXP3, IFN-\u00b3, and suppressive cytokines in high-grade lesion samples infected with human papillomavirus","volume":"53","author":"Bonin","year":"2017","journal-title":"J. Bras. Patol. Med. Lab."},{"key":"10.1016\/j.pvr.2017.08.002_bib128","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3892\/or.2012.1984","article-title":"Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation","volume":"28","author":"Sato","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.pvr.2017.08.002_bib129","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pvr.2017.08.002_bib130","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2016.6073","article-title":"Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.pvr.2017.08.002_bib131","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3892\/or.2015.4435","article-title":"Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8(+) T cells","volume":"35","author":"Leng","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.pvr.2017.08.002_bib132","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.pvr.2017.08.002_bib133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/2326-6066.CIR-14-0149","article-title":"High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer","volume":"3","author":"Heeren","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.pvr.2017.08.002_bib134","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/cgt.2015.40","article-title":"An HPV-E6\/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression","volume":"22","author":"Rice","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.pvr.2017.08.002_bib135","doi-asserted-by":"crossref","first-page":"e1147641","DOI":"10.1080\/2162402X.2016.1147641","article-title":"A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice","volume":"5","author":"Liu","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pvr.2017.08.002_bib136","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/CJI.0000000000000156","article-title":"DNA vaccine encoding HPV16 oncogenes E6 and E7 induces potent cell-mediated and humoral immunity which protects in tumor challenge and drives E7-expressing skin graft rejection","volume":"40","author":"Chandra","year":"2017","journal-title":"J. Immunother."},{"key":"10.1016\/j.pvr.2017.08.002_bib137","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pvr.2017.08.002_bib138","unstructured":"Merck Sharp, Dohme Corp, A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158). \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02628067\u3009 (Accessed 7 August 2017). ClinicalTrials.gov Identifier: NCT02628067."},{"key":"10.1016\/j.pvr.2017.08.002_bib139","unstructured":"Bristol-Myers Squibb, Non-Comparative, Open-Label, Multiple Cohort, Phase 1\/2 Study of Nivolumab Monotherapy and Nivolumab Combination Therapy in Subjects With Virus-Positive and Virus-Negative Solid Tumors. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02488759\u3009 (Accessed 7 August 2017). ClinicalTrials.gov Identifier: NCT02488759."}],"container-title":["Papillomavirus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852117300496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405852117300496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:02:11Z","timestamp":1762513331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405852117300496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":139,"alternative-id":["S2405852117300496"],"URL":"https:\/\/doi.org\/10.1016\/j.pvr.2017.08.002","relation":{},"ISSN":["2405-8521"],"issn-type":[{"value":"2405-8521","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of antigen presenting cell functions during chronic HPV infection","name":"articletitle","label":"Article Title"},{"value":"Papillomavirus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pvr.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}